UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Lung-Seeking Metastases

Cancers, 2019-07, Vol.11 (7), p.1010

2019

Volltextzugriff (PDF)

The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives

International journal of molecular sciences, 2023-12, Vol.25 (1), p.547

2023

Volltextzugriff (PDF)

The Genes-Stemness-Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints

International journal of molecular sciences, 2023-02, Vol.24 (4), p.3496

2023

Volltextzugriff (PDF)

Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study

BMC cancer, 2021-07, Vol.21 (1), p.1-762, Article 762

2021

Volltextzugriff (PDF)

Brain Metastases from Lung Cancer: Is MET an Actionable Target?

Cancers, 2019-02, Vol.11 (3), p.271

2019

Volltextzugriff (PDF)

Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics

The lancet respiratory medicine, 2013-05, Vol.1 (3), p.251-261

2013

Volltextzugriff (PDF)

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

EMBO molecular medicine, 2020-07, Vol.12 (7), p.e11756-n/a

2020

Volltextzugriff (PDF)

Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

Journal of translational medicine, 2016-09, Vol.14 (1), p.256-256, Article 256

2016

Volltextzugriff (PDF)

Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage

Journal of clinical medicine, 2023-02, Vol.12 (4), p.1561

2023

Volltextzugriff (PDF)

Erratum: Stella, G.M. et al. Brain Metastases from Lung Cancer: Is MET an Actionable Target? Cancers 2019, 11 , 271

Cancers, 2019-05, Vol.11 (5), p.644

2019

Volltextzugriff (PDF)

EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells

Journal of cancer research and clinical oncology, 2013-08, Vol.139 (8), p.1327-1335

2013

Volltextzugriff (PDF)

The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma

Journal of clinical medicine, 2021-03, Vol.10 (5), p.1034

2021

Volltextzugriff (PDF)

Erratum to: Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

Journal of translational medicine, 2017-09, Vol.15 (1), p.194-194, Article 194

2017

Volltextzugriff (PDF)

MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin

EBioMedicine, 2017-10, Vol.24 (C), p.34-42

2017

Volltextzugriff (PDF)

Activation of Oncogenic Pathways in Idiopathic Pulmonary Fibrosis

Translational oncology, 2014-10, Vol.7 (5), p.650-655

2014

Volltextzugriff (PDF)

Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report

Orphanet journal of rare diseases, 2007-03, Vol.2 (1), p.14-14, Article 14

2007

Volltextzugriff (PDF)

Carbon nanotubes and pleural damage: perspectives of nanosafety in the light of asbestos experience

Biointerphases, 2011-06, Vol.6 (2), p.P1-P17

Stella, Giulia M

2011

Volltextzugriff (PDF)

Targeting EGFR in non-small-cell lung cancer: Lessons, experiences, strategies

Respiratory medicine, 2012-02, Vol.106 (2), p.173-183

2012

Volltextzugriff (PDF)

Partition analysis of data of two waves of COVID-19 pandemic: is the landscape really evolving? A single institution experience

Minerva medica, 2023-04, Vol.114 (2), p.244

2023

Volltextzugriff (PDF)

Reply to Althuwaybi et al. : Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease: A Potential Role for Aerodigestive Pathophysiology?

American journal of respiratory and critical care medicine, 2021-02, Vol.203 (4), p.522-524

2021

Volltextzugriff (PDF)

MET mutations in cancers of unknown primary origin (CUPs)

Human mutation, 2011-01, Vol.32 (1), p.44-50

2011

Volltextzugriff (PDF)

Targeting the MET oncogene in cancer and metastases

Expert opinion on investigational drugs, 2010-11, Vol.19 (11), p.1381-1394

2010

Volltextzugriff (PDF)

Unexpected responses to EGFR inhibition in NSCLC

Respiratory medicine case reports, 2015-01, Vol.16 (C), p.32-34

2015

Volltextzugriff (PDF)

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

BMC cancer, 2015-05, Vol.15 (1), p.374-374, Article 374

2015

Volltextzugriff (PDF)

COVID-19 epidemic in a Respiratory Diseases Unit: predictor ranking and mining

Journal of thoracic disease, 2021-04, Vol.13 (4), p.2569-2574

2021

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(98)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Lung-Seeking Metastases

The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives

The Genes-Stemness-Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints

Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study

Brain Metastases from Lung Cancer: Is MET an Actionable Target?

Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage

Erratum: Stella, G.M. et al. Brain Metastases from Lung Cancer: Is MET an Actionable Target? Cancers 2019, 11 , 271

EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells

The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma

Erratum to: Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin

Activation of Oncogenic Pathways in Idiopathic Pulmonary Fibrosis

Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report

Carbon nanotubes and pleural damage: perspectives of nanosafety in the light of asbestos experience

Targeting EGFR in non-small-cell lung cancer: Lessons, experiences, strategies

Partition analysis of data of two waves of COVID-19 pandemic: is the landscape really evolving? A single institution experience

Reply to Althuwaybi et al. : Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease: A Potential Role for Aerodigestive Pathophysiology?

MET mutations in cancers of unknown primary origin (CUPs)

Targeting the MET oncogene in cancer and metastases

Unexpected responses to EGFR inhibition in NSCLC

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

COVID-19 epidemic in a Respiratory Diseases Unit: predictor ranking and mining

Suchergebnisse filtern